HYPOTHYROIDISM

INTRODUCTION

Hypothyroidism is defined as a deficiency in thyroid hormone

secretion and action that produces a variety of clinical signs and
symptoms of Hypometabolism.

Overt Hypothyroidism is defined as an elevated serum TSH

concentration (usually above 10 mIU/L) and reduced free
Thyroxine concentration (fT4)
2. Subclinical Hypothyroidism is defined as serum TSH above the
upper reference limit in combination with a normal free Thyroxine
(fT4)
1.

Prevalence

According to a projection from various studies on Thyroid disease,

it has been estimated that about 42 million people in India suffer
from Thyroid diseases. The prevalence of Hypothyroidism was
3.9%. The prevalence of subclinical Hypothyroidism was 9.4%. In
women, the prevalence was higher, at 11.4%, when compared
with men, in whom the prevalence was 6.2%. The prevalence of
subclinical Hypothyroidism increased with age. About 53% of
subjects with subclinical hypothyroidism were positive for antiTPO antibodies.

CLINICAL PRESENTATION

Hypothyroidism
can
affect
all
organ
systems
&
these manifestations are largely independent of the
underlying disorder but are a function of the degree of
hormone deficiency.

CAUSES OF HYPOTHYROIDISM

HASHIMOTOS THYROIDITIS

Hashimotos Thyroiditis is an autoimmune disease in which the thyroid gland is

attacked by a variety of cell and antibody-mediated immune processes, causing
primary Hypothyroidism. The resulting inflammation from Hashimotos disease,
also known as Chronic Lymphocytic Thyroiditis, often leads to an underactive
Thyroid gland (Hypothyroidism).

The diagnosis of Hashimotos Thyroiditis is supported by recognition of

autoantibodies against TPO or Thyroglobulin. 90% of patients with Hashimotos
Thyroiditis have anti-TPO antibodies and anti-Thyroglobulin antibodies, making
these antibodies excellent markers for Hashimotos Thyroiditis. Anti-TPO antibody
positivity is more common at the time of diagnosis than anti-Thyroglobulin
antibody.

Hypothyroidism in Pregnancy

Convincing data suggest that pregnant women who are positive for Thyroid
autoantibodies (especially anti-TPO antibodies) leads to higher frequency of miscarriage
(13.8%) than is seen in pregnant women who lack anti-TPO antibodies (2.4%), and that T4
treatment of the anti-TPO antibody positive group reduces the risk of miscarriage to
approximately 3.5%.
Over Hypothyroidism (OH) in pregnancy is defined as an elevated TSH (>2.5 mIU/L)
in conjunction with a decreased FT4 concentration. Women with TSH levels of 10.0 mIU/L
or above, irrespective of their FT4 levels, are also considered to have OH.
Sub-clinical Hypothyroidism (SCH) in pregnancy is defined as a serum TSH between 2.5
and 10 mIU/L with a normal FT4 concentration.
Isolated Hypothyroxinemia (IH) is defined as a normal maternal TSH concentration
in conjunction with FT4 concentrations in the lower 5th or 10th percentile of the
reference range.

Prevalence

10%-20% of all pregnant women in the first trimester of pregnancy are Thyroid
Peroxidase (TPO) or Thyroglobulin (Tg) antibody positive and Euthyroid
16% of the women who are Euthyroid and positive for TPO or Tg antibody in the
first trimester will develop a TSH that exceeds 4.0 mIU/L by the third trimester,
and 33%-50% of women who are positive for TPO or Tg antibody in the first
trimester will develop postpartum Thyroiditis
2%3% of apparently healthy, non-pregnant women of childbearing age have an
elevated serum TSH. Among these healthy non-pregnant women of childbearing
age it is estimated that 0.3%-0.5% of them would, after having Thyroid function
tests, be classified as having OH, while 2%2.5% of them would be classified as
having SCH

Specific adverse outcomes associated

with maternal Hypothyroidism include:

An increased risk of premature birth, low birth weight, and miscarriage. Such
patients carry an estimated 60% risk of fetal loss when OH was not adequately
detected and treated

Negro and colleagues published data suggesting SCH also increases the risk
of pregnancy complications in anti-thyroid peroxidase antibody positive
(TPOAb+) women

Negro et al. reported a significantly higher miscarriage rate in TPOAb+_ women

with TSH levels between 2.5 and 5.0 mIU/ L compared with those with TSH levels
below 2.5 mIU/L

Recommendations:

Women who are positive for TPOAb and have SCH should be treated with LT4

Women with SCH in pregnancy, who are not initially treated, should be
monitored for progression to OH with a serum TSH and FT4 approximately every 4
weeks until 16-20 weeks gestation and at least once between 26 and 32 weeks
gestation

Isolated Hypothyroxinemia should not be treated in pregnancy

Recommendations:

Anti-Thyroid Peroxidase Antibody (TPOAb) measurements should be considered

when evaluating patients with subclinical Hypothyroidism.

If anti-thyroid antibodies are positive, Hypothyroidism occurs at a rate of 4.3%

per year versus 2.6% per year when anti-thyroid antibodies are negative.
Assessment of serum free T4, in addition to TSH, should be considered when
monitoring L-thyroxine therapy.
Treatment based on individual factors for patients with TSH levels between the
upper limit of a given laboratorys reference range and 10 mIU/L should be
considered particularly if patients have symptoms suggestive of Hypothyroidism,
positive TPOAb or evidence of atherosclerotic cardiovascular disease, heart
failure, or associated risk factors for these diseases.

Recommendations:

Patients whose serum TSH levels exceed 10 mIU/L are at increased risk for heart
failure and cardiovascular mortality, and should be considered for treatment with
L-thyroxine.

Euthyroid women (not receiving LT4) who are TPOAb + require monitoring
for Hypothyroidism during pregnancy. In addition to the risk of Hypothyroidism, it
has been described that being TAb + constitutes a risk factor for miscarriage,
premature delivery, Perinatal death , post-partum dysfunction, and low motor and
intellectual development (IQ) in the offspring.

TEST RANGE AVAILABLE

References:

1.

Indian Journal of Endocrinology & Metabolism. 2011 Jul; 15(Suppl2): S78S81.

2.

Williams text book of Endocrinology, Eleventh edition

3.

Tietz Textbook of Clinical Biochemistry, Fifth Edition

4.

Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the

American Association of Clinical Endocrinologists and the American Thyroid
Association

References:

1.

Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A

2010 Universal screening versus case finding for detection and treatment of
thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab
95:16991707.

2.

Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A

2010 Increased pregnancy loss rate in thyroid antibody negative women with
TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin
Endocrinol Metab 95:E448

For more information about Health Disease visit https://www.lalpathlabs.com

Hyperthyroidism